Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$40.25 - $52.99 $1.12 Million - $1.47 Million
-27,790 Reduced 5.37%
489,767 $20.3 Million
Q1 2024

Apr 30, 2024

SELL
$47.98 - $54.4 $782,409 - $887,100
-16,307 Reduced 3.05%
517,557 $28.1 Million
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $13,816 - $16,487
-285 Reduced 0.05%
533,864 $27.4 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $65,010 - $72,691
-1,123 Reduced 0.21%
534,149 $31 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $242,798 - $269,590
3,811 Added 0.72%
535,272 $34.2 Million
Q1 2023

May 08, 2023

SELL
$65.71 - $74.53 $106,515 - $120,813
-1,621 Reduced 0.3%
531,461 $36.8 Million
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $11.7 Million - $13.9 Million
171,129 Added 47.28%
533,082 $38.4 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $1,115 - $659,440
8,582 Added 2.43%
361,953 $25.7 Million
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $8.68 Million - $9.56 Million
-119,522 Reduced 25.27%
353,371 $27.2 Million
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $21,272 - $25,507
-346 Reduced 0.07%
472,893 $34.5 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $3.67 Million - $4.28 Million
68,423 Added 16.9%
473,239 $29.5 Million
Q3 2021

Nov 09, 2021

SELL
$59.17 - $69.31 $131,712 - $154,284
-2,226 Reduced 0.55%
404,816 $24 Million
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $801,548 - $872,886
12,947 Added 3.29%
407,042 $27.2 Million
Q1 2021

Apr 29, 2021

BUY
$59.34 - $66.74 $6.52 Million - $7.33 Million
109,859 Added 38.65%
394,095 $24.9 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $16.4 Million - $18.6 Million
284,236 New
284,236 $17.6 Million
Q1 2020

Apr 23, 2020

SELL
$46.4 - $67.43 $55,216 - $80,241
-1,190 Closed
0 $0
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $58,559 - $76,386
1,190 New
1,190 $76,000
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $3.66 Million - $3.99 Million
-61,045 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $27,283 - $31,487
494 Added 0.82%
61,045 $3.89 Million
Q2 2017

Aug 14, 2017

BUY
N/A
60,551
60,551 $3.37 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Empire Life Investments Inc. Portfolio

Follow Empire Life Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Empire Life Investments Inc. with notifications on news.